Woman Survived 60 Years With a Brain Condition That Should Have Killed Her

For six decades, a French woman endured excruciating headaches so severe they defied conventional diagnosis, a medical mystery that only unraveled when advanced neuroimaging revealed a cavernous sinus aneurysm so large it should have been fatal—a case now challenging long-held assumptions about cerebrovascular resilience and chronic pain syndromes.

Key Clinical Takeaways:

• A 60-year history of intractable headaches was ultimately traced to a giant intracranial aneurysm, a finding exceptionally rare in its chronicity and lack of rupture.
• The aneurysm, measuring 22mm, resided in the cavernous sinus—a location typically associated with rapid neurological decline—yet remained stable for decades without hemorrhage.
• This case underscores the limitations of relying solely on headache chronology to exclude life-threatening vascular pathology and highlights the role of advanced imaging in uncovering occult diagnoses.

The patient, identified only as a 78-year-old woman from southeastern France, first sought medical attention in her late teens for recurrent, debilitating cephalgia described as “explosive” and unilateral, often accompanied by photophobia and transient cranial nerve deficits. Over six decades, she consulted numerous neurologists, underwent multiple lumbar punctures, and was repeatedly diagnosed with refractory migraine or tension-type headache—diagnoses that persisted despite prophylactic trials of beta-blockers, anticonvulsants, and even botulinum toxin injections, all yielding minimal relief. Her pain burden was immense: intermittent but incapacitating episodes averaging 15 days per month, significantly impairing vocational function and quality of life, yet she never exhibited signs of subarachnoid hemorrhage, seizures, or progressive motor decline that might have prompted earlier vascular investigation.

The diagnostic breakthrough occurred incidentally during a routine geriatric evaluation when MRI angiography, ordered to rule out slight vessel disease, revealed a giant saccular aneurysm arising from the internal carotid artery just proximal to its intracavernous segment. Measuring 22mm at its largest dimension—well above the 15mm threshold defining “giant” aneurysms—the lesion demonstrated slow flow on time-resolved imaging and lacked enhancement patterns suggestive of recent thrombosis or inflammation. Crucially, digital subtraction angiography confirmed a narrow neck and absence of daughter sacs, features typically associated with lower rupture risk, though the aneurysm’s sheer size and location traditionally portend an annual hemorrhage risk exceeding 5%.

“What makes this case extraordinary is not just the aneurysm’s size, but its extraordinary durability in a high-stress hemodynamic environment. The cavernous sinus exposes aneurysms to turbulent flow and mechanical stress from cranial nerve pulsation—yet this lesion remained quiescent for six decades. It suggests unique endothelial adaptation or thrombus-mediated stabilization we don’t yet fully understand.”

Epidemiologically, giant intracranial aneurysms constitute less than 5% of all cerebral aneurysms, with cavernous sinus locations representing only 10-15% of those. Most present acutely with cranial neuropathies (notably oculomotor palsy) or hemorrhage; chronic headache as the sole presenting symptom for six decades is virtually unprecedented in the literature. A 2022 meta-analysis of 1,200 giant aneurysms published in Journal of Neurosurgery found a median symptom duration of 14 months before diagnosis, with 89% presenting with either hemorrhage or focal neurological deficits. The French case extends this timeline by two orders of magnitude, raising questions about phenotypic variability in aneurysm pathogenesis.

Biologically, the aneurysm’s stability may reflect a rare equilibrium between wall stress and thrombotic occlusion. Histopathological analysis of resected giant aneurysms often reveals layered thrombus, neointimal hyperplasia, and medial degeneration—processes that could, in theory, create a pseudo-stable lumen over time. However, sustained stability without progression or rupture for 60 years implies additional modulating factors, possibly genetic polymorphisms in collagen synthesis (e.g., COL3A1 variants) or chronic inflammatory milieu that promoted organized thrombosis without embolization. No familial aneurysm syndrome was identified in the patient’s pedigree, and genetic screening for connective tissue disorders was negative.

Funded by a grant from the French National Research Agency (ANR-21-CE17-0023) as part of a broader study on incidental neurovascular findings in aging populations, the case was managed conservatively after multidisciplinary review. Given her advanced age, the aneurysm’s documented stability, and the high procedural risk associated with cavernous sinus intervention (including cranial neuropathy rates exceeding 20% with endovascular flow diversion), the team opted for serial imaging surveillance rather than intervention. At 18-month follow-up, the aneurysm remains unchanged in size and morphology, and her headache frequency has decreased to approximately 8 days per month—possibly attributable to reduced anxiety following diagnosis or age-related vascular stiffening altering hemodynamic forces.

This case presents a critical triage challenge for clinicians: when does chronic headache warrant neurovascular imaging? Current guidelines from the International Headache Society reserve neuroimaging for atypical features such as sudden onset, progressive worsening, or neurological deficits—criteria this patient lacked for decades. Yet her experience reveals a dangerous blind spot: the assumption that long-standing headache equates to benign etiology. For patients with refractory cephalgia unresponsive to standard migraine prophylaxis, especially those with episodic autonomic features or unexplained cranial nerve variability, early referral to neurovascular specialists is prudent.

For individuals enduring persistent, unexplained headache patterns despite aggressive symptomatic management, accessing specialized neurological evaluation is essential. It is strongly advised to consult with vetted board-certified neurologists equipped with advanced neurovascular imaging capabilities. When diagnostic uncertainty persists, engaging certified headache medicine specialists can help disentangle primary headache disorders from secondary vascular or inflammatory mimics—ensuring that rare but treatable pathologies like this giant aneurysm are not missed in the pursuit of a migraine label.

The enduring mystery of this woman’s six-decade headache journey ultimately serves as a humbling reminder: chronicity does not imply benignity. As imaging technologies become more accessible and cerebrovascular pathophysiology better understood, we may uncover more cases where extraordinary vascular lesions masquerade as ordinary pain—challenging us to refine our diagnostic thresholds without succumbing to diagnostic overreach.

Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.